SCHEMBL17157868

SCHEMBL17157868

CON(C)C(=O)/C=C/c1cccc(Br)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B3 P37058 1/20 0.63
▸ SLC6A19 Q695T7 1/20 0.55
▸ CYP2D6 P10635 1/20 0.54
▸ CYP1B1 Q16678 1/20 0.54
▸ PKM P14618 1/20 0.52
▸ BACE1 P56817 1/20 0.51
▸ MAOB P27338 3/20 0.51
▸ MAOA P21397 1/20 0.51
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ ALOX5 P09917 1/20 0.49
▸ PTGS1 P23219 1/20 0.49
▸ PTGS2 P35354 1/20 0.49
▸ APP P05067 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ POLB P06746 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17157870 1.00 HSD17B3 (0.63) HSD17B3SLC6A19CYP2D6CYP1B1PKM
SCHEMBL481195 0.87 HSD17B3 (0.67) HSD17B3SLC6A19CYP2D6CYP1B1PKM
SCHEMBL16899699 0.87 HSD17B3 (0.67) HSD17B3SLC6A19CYP2D6CYP1B1PKM
SCHEMBL6318820 0.81 MAOB (0.62) CYP2D6CYP1B1MAOBMAOANPC1
SCHEMBL5677002 0.81 NFE2L2 (0.52) MAOBMAOAMEN1KMT2ANPC1
SCHEMBL1225056 0.81 CYP1A2 (0.63) CYP2D6CYP1B1MAOBMAOAMEN1
SCHEMBL6320363 0.81 MAOB (0.62) CYP2D6CYP1B1MAOBMAOANPC1
SCHEMBL5676995 0.81 NFE2L2 (0.52) MAOBMAOAMEN1KMT2ANPC1
SCHEMBL1225052 0.81 CYP1A2 (0.63) CYP2D6CYP1B1MAOBMAOAMEN1
SCHEMBL322249 0.81 HSD17B3 (0.67) HSD17B3SLC6A19CYP2D6CYP1B1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376420-B2 4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same YUHAN CORPORATION (KR) 2016-06-28 — — US disclosed
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME YUHAN CORPORATION (KR) 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME NR1H3, NR1H2, NR1H4 HSD17B3 67/4885SLC6A19 2928/4885CYP2D6 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback